PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Image Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ISI Expands Global Presence with Opening of Tianjin China Office - New operation bolsters Image Solutions' global support capabilities in response to clients’ growing presence in Asian markets and increased need for speed
ISI Expands Global Presence with Opening of Tianjin China Office

 

NewswireToday - /newswire/ - Whippany, NJ, United States, 2007/05/29 - New operation bolsters Image Solutions' global support capabilities in response to clients’ growing presence in Asian markets and increased need for speed.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Image Solutions Inc., (ISI), a leader in providing software and services to streamline the drug development lifecycle, announced today the opening of new operations in Tianjin, China. ISI’s expansion in Asia supports the company’s overall commitment to support the globalization of the Life Science Industry. The China operation adds to ISI’s already strong capabilities that exist in Asia through its development center in Korea, testing and support capabilities in India, and in Japan through an alliance with CAC Corporation.

ISI is enhancing its global capabilities to keep pace with its clients’ needs to respond to increased regulatory pressures, the need to reduce overall costs, and the requirement to speed submission timetables. In addition, China has emerged as a preferred location for new markets and lower-cost drug development and manufacturing. Accordingly, ISI is well positioned for the anticipated growth in this region.

The opening of the operation also represents a strategic decision on ISI’s part to blend global resources and services providing unprecedented support for client requirements. For ISI clients, the foremost Life Science organizations in the world, each day of document processing translates into potential lost revenues downstream.

To satisfy this demand for speed and efficiency, ISI can now link multiple offices located in different time zones, and use web-based technology to provide almost 400 man-hours of production time within a single 24 hour day. This capability provides ISI with a unique competitive advantage to meet client timeframes and achieve their goals quickly and cost-effectively.

The focus for the China operation in the short term is CRF Processing. CRFs are the most paper-intensive document process in the Life Science industry with more than five million CRF pages generated each week. CRF processing has been the backbone of ISI services since its inception. To date, ISI has processed more than 50 million pages of CRFs for submission to the FDA. ISI’s CRF services are part of a broad portfolio of business process outsourcing services developed to assist companies in reducing the time and cost associated with compiling electronic submissions, managing data, and preparing scientific documents.

Because of ISI’s ongoing commitment to quality, the operation in China is expected to be ISO certified later in 2007. ISO is a global, centrally managed certification given after rigorous review of standard operating procedures and the assurance that all processes and procedures are centrally controlled. These methods help ISI provide predictable project estimates and stable, high-quality deliverables and demonstrate ISI’s strong commitment to quality by achieving the highest industry standard.

With record performance over the past several years, ISI is aggressively growing operations in the United States, Europe and Asia. This year alone, ISI plans to expand it’s presence in the United States with the opening of operations in two primary biotechnology hotbed regions: Boston, Massachusetts, and San Diego, California. In Europe, ISI will have an increased presence in the United Kingdom.

About Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. (imagesolutions.com) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. ISI was among the first professional services firm to deliver electronic submissions to the industry and since has delivered nearly 1,000 electronic submissions and 400 eCTD submissions. ISI serves the top 50 pharmaceutical and biotech organizations as well as the top companies in other regulated industries.

ISI is a privately held company with headquarters in Whippany, New Jersey and operations throughout the U.S., Europe and Asia. ISI also remains committed to giving back to society and sharing its success with others by donating 10 percent of annual net profits to over 20 recognized charitable organizations.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Image Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


ISI Expands Global Presence with Opening of Tianjin China Office

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Keith Ward - ImageSolutions.com 
973-560-0404 x324 keith.ward[.]imagesolutions.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Image Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Image Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)